Acrivon Therapeutics, Inc Common Stock

Price & Volume

Stats

52W Range	$1.05-$6.08
Market Cap	$52.6M
Shares Short	7M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$2.12

News

Yahoo Finance • 2 months ago

3 Promising Penny Stocks With Market Caps Over $70M

Yahoo Finance • 3 months ago

Acrivon Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights

Yahoo Finance • 4 months ago

Acrivon Therapeutics Highlights its Powerful Generative Phosphoproteomics AP3 Platform with Compelling Preclinical Data for ACR-2316 with Three Presentations at the Upcoming AACR-NCI-EORTC International Conference

Yahoo Finance • 4 months ago

Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

About

CEO	Dr. Peter Blume-Jensen M.D., Ph.D.
CFO	Dr. Adam D. Levy M.B.A., Ph.D.
Address	480 Arsenal Way, Watertown, MA, United States, 02472
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	75